7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-06-30 2022-03-31 2021-09-30 2021-06-30 2021-03-31 2020-06-30 2020-03-31 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2014-12-31 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2011-12-31 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 
      
    		                                                          
      cash flows from (used by) operating activities:
    		                                                          
      net income
    		147,000,000 83,000,000 85,000,000 30,000,000 118,000,000 110,000,000 169,000,000 60,000,000 228,000,000 94,000,000 219,000,000 179,000,000 318,000,000 240,000,000 195,000,000 71,999,510 -72,000,000 230,000,000 210,000,000 249,000,000 165,000,000 265,000,000 175,000,000 271,000,000 216,000,000 220,000,000 108,000,000 -240,000,000 -238,000,000 -708,000,000 219,000,000 245,000,000 148,000,000 180,000,000 141,000,000 70,000,000 140,000,000 116,000,000 -126,000,000 122,000,000 77,000,000 212,000,000 75,000,000 45,000,000 -50,000,000 -469,000,000 -321,000,000 -258,000,000 -109,000,000 116,000,000 178,000,000 339,000,000 379,000,000 324,000,000 373,000,000    
      less income from discontinued operations, net of taxes
    		8,000,000 7,000,000 5,000,000    1,000,000               0                             0 0       
      adjustments to reconcile net income to net cash from (used by) operating activities:
    		                                                          
      amortization of fixed maturity securities discounts and premiums
    		-36,000,000 -37,000,000 -32,000,000 -28,000,000 -27,000,000 -41,000,000 -23,000,000 -26,000,000 -33,000,000 -25,000,000 -50,000,000 -34,000,000 -58,000,000 -48,000,000 -32,000,000 34,999,950 -35,000,000 -16,000,000 -30,000,000                                        
      net investment (gains) losses
    		-99,000,000 28,000,000 -27,000,000 41,000,000 -66,000,000 61,000,000 -49,000,000 43,000,000 -39,000,000 11,000,000 -8,000,000 -28,000,000  -70,000,000 -33,000,000 -152,000,007 152,000,000 -74,000,000 -13,000,000 14,000,000 31,000,000    -34,000,000                                  
      changes in fair value of market risk benefits and associated hedges
    		-1,000,000 -10,000,000 18,000,000 -3,000,000 21,000,000 -8,000,000 -23,000,000 -24,000,000 -19,000,000 17,000,000                                                 
      charges assessed to policyholders
    		-133,000,000 -138,000,000 -138,000,000 -135,000,000 -144,000,000 -146,000,000 -139,000,000 -139,000,000 -147,000,000 -144,000,000 -142,000,000 -150,000,000 -155,000,000 -158,000,000 -159,000,000 157,999,686 -158,000,000 -165,000,000 -169,000,000 -181,000,000 -178,000,000 -179,000,000 -169,000,000 -182,000,000 -183,000,000 -193,000,000 -191,000,000 -202,000,000 -193,000,000 -197,000,000 -187,000,000 -200,000,000 -208,000,000 -202,000,000 -202,000,000 -202,000,000 -183,000,000 -159,000,000 -139,000,000 -134,000,000 -120,000,000 -113,000,000 -110,000,000 -121,000,000 -108,000,000 -103,000,000 -105,000,000 -108,000,000 -96,000,000 -100,000,000 -106,000,000 -96,000,000 -98,000,000 -97,000,000 -83,000,000 -78,000,000 -91,000,000 -86,000,000 
      amortization of deferred acquisition costs and intangibles
    		57,000,000 57,000,000 60,000,000 62,000,000 62,000,000 60,000,000 65,000,000 65,000,000 64,000,000 72,000,000 84,000,000 92,000,000 106,000,000 86,000,000 77,000,000 -115,999,791 116,000,000 91,000,000 83,000,000 112,000,000 104,000,000 119,000,000 83,000,000 139,000,000 94,000,000 112,000,000 99,000,000 207,000,000 563,000,000 156,000,000 134,000,000 128,000,000 182,000,000 137,000,000 122,000,000 162,000,000 171,000,000 185,000,000 166,000,000 227,000,000 179,000,000 184,000,000 180,000,000 143,000,000 212,000,000 247,000,000 264,000,000 208,000,000 209,000,000 203,000,000 209,000,000 202,000,000 207,000,000 213,000,000 176,000,000 170,000,000 208,000,000 173,000,000 
      deferred income taxes
    		-9,000,000 -22,000,000 2,000,000 -46,000,000 -7,000,000 -49,000,000 -1,000,000 28,000,000 70,000,000 37,000,000 71,000,000 57,000,000 70,000,000 73,000,000 59,000,000 11,000,028 -11,000,000 75,000,000 32,000,000 57,000,000 26,000,000 -602,000,000 68,000,000 73,000,000 93,000,000 -3,000,000 7,000,000 -79,000,000 -220,000,000 -293,000,000 17,000,000 41,000,000 93,000,000 -31,000,000 -182,000,000 -32,000,000 -151,000,000 -37,000,000 -183,000,000 62,000,000 -72,000,000 -101,000,000 158,000,000 -43,000,000 -89,000,000 -502,000,000 -177,000,000 -307,000,000 29,000,000 25,000,000 35,000,000 64,000,000 80,000,000 73,000,000 149,000,000 37,000,000 59,000,000 123,000,000 
      derivative instruments, limited partnerships and other
    		-108,000,000 -133,000,000 -27,000,000 -118,000,000 -80,000,000 -125,000,000 -138,000,000 -156,000,000 -138,000,000 -84,000,000 -58,000,000 -105,000,000 -63,000,000 -76,000,000 -113,000,000 -346,999,809 347,000,000                                          
      long-term incentive compensation expense
    		17,000,000 14,000,000 11,000,000 14,000,000 12,000,000 11,000,000 14,000,000                                                    
      change in certain assets and liabilities:
    		                                                          
      accrued investment income and other assets
    		-10,000,000 -3,000,000 -47,000,000 -24,000,000 10,000,000 -30,000,000 -68,000,000 -58,000,000 7,000,000 -73,000,000 -27,000,000 -43,000,000 -48,000,000 -11,000,000 -58,000,000 106,999,869 -107,000,000 -258,000,000 -42,000,000 -44,000,000 -45,000,000 51,000,000 2,000,000 56,000,000 -79,000,000 -27,000,000 -159,000,000 27,000,000 -82,000,000 43,000,000 -109,000,000 23,000,000 -87,000,000 63,000,000 -42,000,000 -165,000,000 12,000,000 -117,000,000 -2,000,000 -55,000,000 67,000,000 -43,000,000 45,000,000 -165,000,000 100,000,000 -70,000,000 -136,000,000 507,000,000 -80,000,000 -239,000,000 38,000,000 -203,000,000 35,000,000 -34,000,000 -17,000,000 -154,000,000 111,000,000 33,000,000 
      insurance reserves
    		252,000,000 187,000,000 149,000,000 287,000,000 217,000,000 133,000,000 140,000,000 378,000,000 252,000,000 273,000,000 245,000,000 249,000,000 171,000,000 181,000,000 326,000,000 -327,999,326 328,000,000 301,000,000 348,000,000 314,000,000 377,000,000 423,000,000 396,000,000 429,000,000 377,000,000 296,000,000 36,000,000 577,000,000 404,000,000 1,443,000,000 550,000,000 577,000,000 496,000,000 642,000,000 541,000,000 671,000,000 550,000,000 557,000,000 639,000,000 559,000,000 632,000,000 576,000,000 610,000,000 633,000,000 1,052,000,000 468,000,000 1,263,000,000 -378,000,000 940,000,000 1,209,000,000 972,000,000 840,000,000 774,000,000 775,000,000 753,000,000 951,000,000 737,000,000 739,000,000 
      current tax liabilities
    		17,000,000 -54,000,000 34,000,000 -94,000,000 11,000,000 30,000,000 67,000,000   2,000,000   -4,000,000 0 -4,000,000 4,999,999 -5,000,000 8,000,000 -11,000,000 2,000,000 -39,000,000 23,000,000 5,000,000 5,000,000 -37,000,000 64,000,000 -8,000,000 56,000,000 20,000,000 7,000,000 -182,000,000 46,000,000 -18,000,000 58,000,000 202,000,000 6,000,000 123,000,000 25,000,000 140,000,000 -102,000,000 -48,000,000 -163,000,000 -174,000,000 -142,000,000 114,000,000 83,000,000 13,000,000 24,000,000 -150,000,000 -25,000,000 -22,000,000 -17,000,000 96,000,000 84,000,000 -53,000,000 64,000,000 -97,000,000 141,000,000 
      other liabilities, policy and contract claims and other policy-related balances
    		-8,000,000 48,000,000 -59,000,000 36,000,000 31,000,000 0 -122,000,000 -1,000,000 10,000,000 -175,000,000 84,000,000 -289,000,000 116,000,000 259,000,000 -319,000,000 -117,999,345 118,000,000 -18,000,000 186,000,000 22,000,000 -144,000,000 628,000,000 -102,000,000 -46,000,000 -112,000,000 -305,000,000 406,000,000 -59,000,000 449,000,000                              
      cash used by operating activities—discontinued operations
    		       0 -1,000,000 -1,000,000   -296,000,000 -18,000,000 -174,000,000                                            
      net cash from (used by) operating activities
    		87,000,000 6,000,000 34,000,000   7,000,000 -107,000,000   17,000,000     -247,000,000                                            
      cash flows from (used by) investing activities:
    		                                                          
      proceeds from maturities and repayments of investments:
    		                                                          
      fixed maturity securities
    		721,000,000 621,000,000 639,000,000 654,000,000 550,000,000 671,000,000 649,000,000 532,000,000 531,000,000 613,000,000 765,000,000 730,000,000 1,033,000,000 1,189,000,000 1,031,000,000 -920,998,313 921,000,000 902,000,000 988,000,000 1,045,000,000 934,000,000 1,370,000,000 1,038,000,000 1,298,000,000 1,060,000,000 840,000,000 840,000,000 1,152,000,000 994,000,000 1,589,000,000 1,135,000,000 994,000,000 1,226,000,000 1,608,000,000 1,212,000,000 1,253,000,000 1,158,000,000 1,627,000,000 1,287,000,000 1,245,000,000 1,116,000,000 941,000,000 948,000,000 1,265,000,000 991,000,000 901,000,000 1,298,000,000 1,171,000,000 1,344,000,000 974,000,000         
      commercial mortgage loans
    		173,000,000 111,000,000 202,000,000 155,000,000 164,000,000 140,000,000 127,000,000 117,000,000 115,000,000 154,000,000 199,000,000 115,000,000 209,000,000 263,000,000 129,000,000 -138,999,698 139,000,000 127,000,000 193,000,000 145,000,000 205,000,000 125,000,000 147,000,000 141,000,000 166,000,000 172,000,000 192,000,000 242,000,000 204,000,000 237,000,000 139,000,000 210,000,000 212,000,000 262,000,000 212,000,000 168,000,000 279,000,000 148,000,000 276,000,000 230,000,000 127,000,000 136,000,000 191,000,000 138,000,000 142,000,000 239,000,000 211,000,000 156,000,000 236,000,000 254,000,000 246,000,000 354,000,000 295,000,000 261,000,000 302,000,000    
      limited partnerships and other invested assets
    		71,000,000 52,000,000 50,000,000 86,000,000 50,000,000 49,000,000 59,000,000 35,000,000 36,000,000 31,000,000 48,000,000 51,000,000                                               
      proceeds from sales of investments:
    		                                                          
      fixed maturity and equity securities
    		417,000,000 708,000,000 334,000,000 501,000,000 421,000,000 1,083,000,000 635,000,000 244,000,000 848,000,000 441,000,000 721,000,000 581,000,000 285,000,000 529,000,000 777,000,000 -368,998,343 369,000,000 1,714,000,000 1,405,000,000 1,128,000,000 792,000,000 957,000,000 682,000,000 414,000,000 2,173,000,000 1,867,000,000 905,000,000 3,058,000,000 512,000,000 745,000,000 708,000,000 1,380,000,000 811,000,000 935,000,000 1,310,000,000 1,418,000,000 2,838,000,000 1,009,000,000 1,314,000,000 936,000,000 1,372,000,000 1,021,000,000 2,465,000,000 1,680,000,000 716,000,000 947,000,000 1,642,000,000 1,272,000,000 1,104,000,000 922,000,000         
      purchases and originations of investments:
    		                                                          
      short-term investments
    		-15,000,000   -2,000,000 11,000,000 -2,000,000 17,000,000 -8,000,000 -8,000,000 1,000,000 26,000,000 -50,000,000 52,000,000 -104,000,000 28,000,000 -47,999,941 48,000,000                                          
      policy loans
    		41,000,000 51,000,000 1,000,000 4,000,000 22,000,000   34,000,000 22,000,000 10,000,000 0 14,000,000 12,000,000 25,000,000 3,000,000 -8,999,990 9,000,000 12,000,000 20,000,000 13,000,000 2,000,000 20,000,000 7,000,000   -100,000,000 10,000,000 2,000,000 20,000,000 1,000,000  249,000,000 -6,000,000   62,000,000 6,000,000 -9,000,000 9,000,000 -13,000,000 -59,000,000 -5,000,000 5,000,000 679,000,000 -245,000,000 -8,000,000 -12,000,000 -16,000,000 -152,000,000 -3,000,000 -1,000,000 -15,000,000 -141,000,000 -5,000,000 4,000,000 -12,000,000 -123,000,000 -12,000,000 
      other
    		-10,000,000 -8,000,000 -7,000,000 -11,000,000 -10,000,000 -18,000,000 -17,000,000 -18,000,000 -22,000,000 2,000,000 -120,000,000 15,000,000 2,000,000 -27,000,000 92,000,000 -99,999,951 100,000,000 48,000,000  -24,000,000 22,000,000 -24,000,000 -1,000,000 -20,000,000 -9,000,000 -4,000,000 13,000,000 -73,000,000 -34,000,000 -19,000,000 -12,000,000 -20,000,000 -36,000,000 15,000,000 -32,000,000 -14,000,000                       
      net cash from (used by) investing activities
    		308,000,000 174,000,000 -14,000,000          -72,000,000 206,000,000 335,000,000  -551,000,000 277,000,000                                         
      cash flows from (used by) financing activities:
    		                                                          
      deposits to universal life and investment contracts
    		125,000,000 129,000,000 129,000,000 127,000,000 135,000,000 139,000,000 133,000,000 134,000,000 155,000,000 148,000,000 155,000,000 159,000,000 162,000,000 173,000,000 176,000,000 -179,999,484 180,000,000 198,000,000 302,000,000 248,000,000 255,000,000 -45,000,000 473,000,000 211,000,000 218,000,000 239,000,000 571,000,000 564,000,000 551,000,000 792,000,000 814,000,000 1,020,000,000 1,059,000,000 475,000,000 445,000,000 897,000,000 648,000,000 560,000,000 905,000,000 658,000,000 684,000,000 490,000,000 470,000,000 530,000,000               
      withdrawals from universal life and investment contracts
    		-211,000,000 -341,000,000 -221,000,000 -251,000,000 -286,000,000 -360,000,000 -317,000,000 -415,000,000 -402,000,000 -491,000,000 -361,000,000 -418,000,000 -439,000,000 -565,000,000 -578,000,000 492,999,086 -493,000,000 -581,000,000 -629,000,000 -586,000,000 -591,000,000 -394,000,000 -912,000,000 -624,000,000 -467,000,000 -504,000,000 -517,000,000 -467,000,000 -598,000,000 -638,000,000 -505,000,000 -656,000,000 -554,000,000 -1,381,000,000 -678,000,000 -551,000,000 -654,000,000 -1,115,000,000 -1,479,000,000 -1,216,000,000 -821,000,000 -913,000,000 -1,306,000,000 -2,438,000,000               
      proceeds from issuance of long-term debt
    		   0 0              0 0 441,000,000       0                               
      debt issuance costs
    		   0 0                                                      
      repayment and repurchase of long-term debt
    		   -31,000,000 -17,000,000 -770,000,000 -6,000,000 0 0 -11,000,000 -48,000,000 -82,000,000 -519,000,000 -14,000,000 -470,000,000 419,999,529 -420,000,000  -1,000,000       -36,000,000 -326,000,000 0  0  0 -350,000,000   0 0                      
      repurchase of subsidiary shares
    		-20,000,000 -16,000,000 -12,000,000 -13,000,000 -14,000,000 -9,000,000 -9,000,000 -1,000,000 -8,000,000 -4,000,000        -12,000,000 -40,000,000 -13,000,000 -36,000,000 -2,000,000      -51,000,000 0   0 -22,000,000    0  0                    
      treasury stock acquired in connection with share repurchases
    		-74,000,000 -32,000,000 -45,000,000 -54,000,000 -36,000,000 -36,000,000 -63,000,000 -80,000,000 -113,000,000 -68,000,000                                                 
      dividends paid to noncontrolling interests
    		-6,000,000 -6,000,000 -5,000,000 -6,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -4,000,000      8,999,991 -9,000,000 -28,000,000 -33,000,000 -14,000,000 -36,000,000 -15,000,000 -40,000,000 -13,000,000 -39,000,000 -12,000,000 -52,000,000 -12,000,000 -79,000,000 -29,000,000 -13,000,000 -13,000,000 -13,000,000 -13,000,000 -13,000,000 -12,000,000 -32,000,000 -12,000,000 -11,000,000 -11,000,000 -11,000,000 -10,000,000                 
      net cash from (used by) financing activities
    		-156,000,000                 -375,000,000   47,000,000                                      
      net change in cash, cash equivalents and restricted cash
    		239,000,000 -94,000,000 -157,000,000 -9,000,000 125,000,000 -20,000,000 -263,000,000 -180,000,000 421,000,000 -47,000,000 433,000,000 -280,000,000 -277,000,000 250,000,000 -692,000,000 857,999,256 -858,000,000 44,000,000 262,000,000 -600,000,000 -32,000,000                                      
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 2,048,000,000 0 0 0 2,215,000,000 0 0 1,799,000,000 0 1,571,000,000 0 0 2,656,000,000 -3,340,996,659 3,341,000,000 2,177,000,000 0 0 2,875,000,000                                      
      cash, cash equivalents and restricted cash at end of period
    		239,000,000 -94,000,000 1,891,000,000 -9,000,000 125,000,000 -20,000,000 1,952,000,000 -180,000,000 421,000,000 1,752,000,000 433,000,000 1,291,000,000 -277,000,000 250,000,000 1,964,000,000 -2,482,997,403 2,483,000,000 2,221,000,000 262,000,000 -600,000,000 2,843,000,000                                      
      cash from (used by) operating activities—discontinued operations
    		                                                          
      net cash used by financing activities
    		  -177,000,000 -255,000,000 -276,000,000 -285,000,000 -299,000,000 -352,000,000 -390,000,000 -428,000,000 -393,000,000 -326,000,000 -265,000,000 -433,000,000 -780,000,000 956,998,856 -957,000,000  -407,000,000   -498,000,000 -515,000,000 -451,000,000 -304,000,000                                  
      adjustments to reconcile net income to net cash from operating activities:
    		                                                          
      net cash from operating activities
    		   27,000,000    175,000,000     61,000,000   -679,998,701 680,000,000 134,000,000 412,000,000 452,000,000 109,000,000 622,000,000 624,000,000 653,000,000 655,000,000 810,000,000 256,000,000 433,000,000 647,000,000 1,298,000,000 61,000,000 306,000,000 447,000,000 586,000,000 60,000,000 207,000,000 1,093,000,000 336,000,000 360,000,000 419,000,000 427,000,000 130,000,000 77,000,000 485,000,000 586,000,000 783,000,000 2,250,000,000 1,073,000,000 995,000,000 1,125,000,000 1,023,000,000 1,226,000,000 1,478,000,000 1,064,000,000 1,015,000,000 1,353,000,000 1,226,000,000 771,000,000 
      net cash from investing activities
    		   220,000,000 240,000,000 258,000,000 143,000,000 -4,000,000 553,000,000 364,000,000 397,000,000 138,000,000              -1,029,000,000 -255,000,000 1,759,000,000 -902,000,000 167,000,000 -204,000,000 -293,000,000 -1,005,000,000 265,000,000 453,000,000 -424,000,000 -145,000,000 496,000,000 -127,000,000 -965,000,000 451,000,000 -1,174,000,000 -1,566,000,000 1,751,000,000 -619,000,000 1,254,000,000 1,794,000,000 -673,000,000 444,000,000 400,000,000 -78,000,000 34,000,000 -1,149,000,000 -687,000,000 -1,344,000,000 -802,000,000 -103,000,000 -649,000,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		               29,999,988 -30,000,000 8,000,000 -10,000,000 -31,000,000 -21,000,000                                      
      less (income) income from discontinued operations, net of taxes
    		    3,000,000      1,000,000 2,000,000 -12,000,000 5,000,000 -21,000,000            19,000,000 73,000,000 21,000,000   0 -2,000,000 -6,000,000 20,000,000                        
      acquisition costs deferred
    		       -2,000,000 -2,000,000 -2,000,000 1,000,000 -2,000,000 -3,000,000 -1,000,000 -2,000,000 3,999,991 -4,000,000 -17,000,000 -23,000,000 -22,000,000 -18,000,000 -21,000,000 -23,000,000 -22,000,000 -22,000,000 -41,000,000 -50,000,000 -67,000,000 -71,000,000 -117,000,000 -119,000,000 -125,000,000 -120,000,000 -107,000,000 -105,000,000 -147,000,000 -213,000,000 -229,000,000 -229,000,000 -218,000,000 -199,000,000 -193,000,000 -167,000,000 -172,000,000 -174,000,000 -194,000,000 -246,000,000 -276,000,000 -338,000,000 -331,000,000 -354,000,000 -315,000,000 -430,000,000 -309,000,000 -357,000,000 -302,000,000 -318,000,000 -289,000,000 
      stock-based compensation expense
    		       12,000,000 10,000,000 15,000,000 10,000,000 10,000,000 7,000,000 14,000,000 11,000,000 -10,999,981 11,000,000 7,000,000 9,000,000 9,000,000 7,000,000 13,000,000 11,000,000 8,000,000 10,000,000 9,000,000 7,000,000 2,000,000 6,000,000 9,000,000 8,000,000 14,000,000 10,000,000 8,000,000 9,000,000 7,000,000 8,000,000 7,000,000 13,000,000 8,000,000 12,000,000 11,000,000 9,000,000 2,000,000 7,000,000 8,000,000 5,000,000 3,000,000 6,000,000 9,000,000         
      less cash, cash equivalents and restricted cash of discontinued operations at end of period
    		                                                          
      cash, cash equivalents and restricted cash of continuing operations at end of period
    		       -180,000,000 421,000,000 1,752,000,000 433,000,000 1,291,000,000 -277,000,000 250,000,000 1,964,000,000 -2,482,997,403 2,483,000,000                                          
      proceeds from sale of business, net of cash transferred
    		            0 0 270,000,000                                            
      cash used by investing activities—discontinued operations
    		            0                                              
      redemption of non-recourse funding obligations
    		               314,999,685 -315,000,000         0 -1,620,000,000  -15,000,000  -8,000,000       -6,000,000 0 0 0 -6,000,000 0 0 0 -12,000,000     0        
      proceeds from sale of subsidiary shares to noncontrolling interests
    		                           0 0                              
      cash used by financing activities—discontinued operations
    		                                                          
      adjustments to reconcile net income to net cash used by operating activities:
    		                                                          
      cash used by operating activities — discontinued operations
    		           -30,000,000                                               
      net cash used by operating activities
    		           -92,000,000                                               
      cash used by investing activities — discontinued operations
    		                                                          
      cash flows from operating activities:
    		                                                          
      net investment gains
    		                      -85,000,000                                    
      other invested assets
    		            69,000,000 63,000,000 44,000,000 -33,999,929 34,000,000 17,000,000 271,000,000 -11,000,000 104,000,000 -180,000,000 117,000,000 38,000,000 -676,000,000 -101,000,000 34,000,000 214,000,000 0 -127,000,000 111,000,000 9,000,000 -33,000,000 139,000,000 -26,000,000 153,000,000 -471,000,000 -59,000,000 96,000,000 -8,000,000 1,147,000,000 344,000,000 -436,000,000 470,000,000   -922,000,000 -307,000,000 80,000,000 -77,000,000 431,000,000 -740,000,000 -99,000,000 -159,000,000 -41,000,000 -41,000,000 -1,000,000 -9,000,000 
      cash flows used by financing activities:
    		                                                          
      cash from financing activities—discontinued operations
    		                            6,000,000   0                   0 0 -11,000,000 -10,000,000     
      cash from (used by) investing activities—discontinued operations
    		              -67,000,000                                            
      goodwill impairment
    		                             299,000,000                             
      derivative instruments and limited partnerships
    		                 -30,000,000                                         
      redemption and repurchase of non-recourse funding obligations
    		                               -8,000,000 -8,000,000 -8,000,000 -4,000,000 -234,000,000 -18,000,000                      
      repayment of borrowings related to securitization entities
    		                  -8,000,000 -4,000,000 -8,000,000 -18,000,000 -4,000,000 -5,000,000 -7,000,000 -20,000,000 -10,000,000 -10,000,000 -7,000,000 -8,000,000 -7,000,000 -57,000,000 -19,000,000 -15,000,000 -17,000,000 -24,000,000 -19,000,000 -12,000,000 -15,000,000 -15,000,000 -20,000,000 -11,000,000                 
      cash from operating activities—discontinued operations
    		                            22,000,000   0 65,000,000 2,000,000 1,000,000                0 0 -2,000,000 27,000,000     
      cash flows used by investing activities:
    		                                                          
      net cash used by investing activities
    		                   -31,000,000 -167,000,000 -81,000,000 -155,000,000 -381,000,000 -142,000,000                                  
      restricted commercial mortgage loans related to a securitization entity
    		                 3,000,000                                         
      repayment of borrowings related to a securitization entity
    		                                                          
      trading securities, limited partnerships and derivative instruments
    		                  -168,000,000                                        
      restricted commercial mortgage loans related to securitization entities
    		                  4,000,000 8,000,000 8,000,000 4,000,000 7,000,000 5,000,000 6,000,000 14,000,000 6,000,000 14,000,000 6,000,000 8,000,000 7,000,000 9,000,000 20,000,000 14,000,000 17,000,000 23,000,000 19,000,000 22,000,000 12,000,000 13,000,000 15,000,000 12,000,000                 
      payments for business purchased, net of cash acquired
    		                      0                                 -157,000,000   
      amortization of fixed maturity securities discounts and premiums and limited partnerships
    		                    -25,000,000 -40,000,000 -31,000,000 -43,000,000 -33,000,000 -29,000,000 -38,000,000  -31,000,000  -28,000,000                            
      trading securities, held-for-sale investments and derivative instruments
    		                    -152,000,000 -13,000,000 285,000,000 66,000,000 365,000,000                                  
      (gain) loss on sale of businesses
    		                                                          
      cash from operating activities—held for sale
    		                                                          
      proceeds from sale of businesses, net of cash transferred
    		                                                          
      payments for businesses purchased, net of cash acquired
    		                                   0 0 -4,000,000         -2,000,000 -3,000,000 -12,000,000 -5,000,000         
      cash used by investing activities—held for sale
    		                                                          
      return of capital to noncontrolling interests
    		                                                          
      cash from financing activities—held for sale
    		                                                          
      effect of exchange rate changes on cash and cash equivalents (includes —, — and (35) related to businesses held for sale
    		                                                          
      net change in cash and cash equivalents
    		                     39,000,000 -17,000,000 -165,000,000 234,000,000 -627,000,000 -1,909,000,000 2,185,000,000 -446,000,000 1,441,000,000 146,000,000 660,000,000 -83,000,000 -182,000,000 166,000,000 -133,000,000 840,000,000 610,000,000 -466,000,000 -988,000,000 1,120,000,000 -1,536,000,000 -2,142,000,000 1,770,000,000 -1,690,000,000 -264,000,000 2,226,000,000 -759,000,000 2,093,000,000 677,000,000 -55,000,000 190,000,000 699,000,000 -212,000,000 167,000,000 -49,000,000 442,000,000 34,000,000 
      cash and cash equivalents at beginning of period
    		                     0 0 0 2,784,000,000 0 5,993,000,000 0 0 0 4,214,000,000 0 0 0 3,653,000,000 0 0 3,132,000,000  0 0 5,002,000,000  0 0 7,328,000,000  0 0 3,091,000,000  0 0 2,469,000,000  0 0 1,875,000,000 
      cash and cash equivalents at end of period
    		                     39,000,000 -17,000,000 -165,000,000 3,018,000,000 -627,000,000 4,084,000,000 2,185,000,000 -446,000,000 1,441,000,000 4,360,000,000 660,000,000 -83,000,000 -182,000,000 3,819,000,000 -133,000,000 840,000,000 3,742,000,000  -988,000,000 1,120,000,000 3,466,000,000  1,770,000,000 -1,690,000,000 7,064,000,000  -759,000,000 2,093,000,000 3,768,000,000  190,000,000 699,000,000 2,257,000,000  -49,000,000 442,000,000 1,909,000,000 
      less cash and cash equivalents held for sale at end of period
    		                          41,000,000                                
      cash and cash equivalents of continuing operations at end of period
    		                        3,018,000,000 -586,000,000 4,043,000,000 2,299,000,000 -434,000,000 1,441,000,000 4,360,000,000 660,000,000 -59,000,000 -184,000,000 3,797,000,000               3,768,000,000  190,000,000 706,000,000 2,250,000,000     
      gain on sale of business
    		                                                          
      effect of exchange rate changes on cash and cash equivalents
    		                      29,000,000 14,000,000 25,000,000 -1,000,000 31,000,000   -80,000,000 20,000,000 -15,000,000 24,000,000 -70,000,000 -48,000,000 22,000,000 26,000,000 -1,000,000 48,000,000 80,000,000 -2,000,000 -5,000,000 -3,000,000 152,000,000 181,000,000 -98,000,000 1,000,000 -176,000,000 -32,000,000 -51,000,000 34,000,000 -46,000,000 22,000,000 -4,000,000 -20,000,000 -9,000,000 3,000,000 -12,000,000 
      net increase in trading securities, held-for-sale investments and derivative instruments
    		                         722,000,000 21,000,000 8,000,000 -54,000,000 96,000,000 26,000,000 -44,000,000 -50,000,000 62,000,000 -27,000,000 -27,000,000 656,000,000 35,000,000 -213,000,000 -6,000,000 61,000,000 58,000,000 -55,000,000                
      cash flows from investing activities:
    		                                                          
      cash from investing activities—held for sale
    		                                                          
      cash flows from financing activities:
    		                                                          
      net cash from financing activities
    		                         -407,000,000 -1,941,000,000 -23,000,000 -146,000,000 56,000,000 269,000,000 662,000,000 451,000,000 -963,000,000 -299,000,000 62,000,000 -134,000,000 -221,000,000 -747,000,000 -522,000,000 244,000,000 -487,000,000 -650,000,000 -618,000,000 -1,838,000,000 -2,203,000,000 -1,819,000,000 -983,000,000 686,000,000 -797,000,000 -1,034,000,000 -1,024,000,000 348,000,000 -585,000,000 516,000,000 -591,000,000 -684,000,000 -76,000,000 
      effect of exchange rate changes on cash and cash equivalents (includes —, (35) and (39) related to businesses held for sale
    		                                                          
      gain on sale of businesses
    		                                                          
      net investment losses
    		                         -30,000,000 19,000,000  51,000,000  17,000,000  23,000,000 -21,000,000 61,000,000 -9,000,000 -5,000,000 28,000,000 39,000,000 -105,000,000 139,000,000 70,000,000 96,000,000 122,000,000 53,000,000 770,000,000  816,000,000 518,000,000 226,000,000  48,000,000 51,000,000 19,000,000     
      gain on sale of subsidiary
    		                          -20,000,000         0       0                
      loss on sale of subsidiary
    		                                                          
      amortization of fixed maturity discounts and premiums and limited partnerships
    		                               -33,000,000 -24,000,000 -35,000,000 -5,000,000 -10,000,000 -6,000,000                      
      proceeds from sale of a subsidiary, net of cash transferred
    		                               -5,000,000 345,000,000   0                       
      effect of exchange rate changes on cash and cash equivalents (includes (35), (39) and —related to businesses held for sale
    		                                                          
      cash from investing activities—discontinued operations
    		                            -35,000,000   0                   0 0 144,000,000 -41,000,000     
      less cash and cash equivalents of discontinued operations at end of period
    		                            -12,000,000     2,000,000 22,000,000                   7,000,000     
      effect of exchange rate changes on cash and cash equivalents (includes and 2 related to discontinued operations
    		                                                          
      proceeds from the issuance of long-term debt
    		                               396,000,000    0 0 397,000,000          0    0       
      proceeds from the sale of subsidiary shares to noncontrolling interests
    		                                          -1,000,000                
      other liabilities and other policy-related balances
    		                              -285,000,000 -340,000,000 -61,000,000 -164,000,000 -474,000,000 -206,000,000 -18,000,000 -57,000,000 299,000,000 77,000,000 -282,000,000 -392,000,000 -571,000,000 310,000,000 -727,000,000 519,000,000 -62,000,000 820,000,000 58,000,000 28,000,000 -119,000,000 517,000,000 468,000,000 -1,000,000 178,000,000 349,000,000 245,000,000 -421,000,000 
      net cash transferred related to the sale of a subsidiary
    		                                          39,000,000                
      short-term borrowings and other
    		                                    -59,000,000 -33,000,000 -691,000,000 199,000,000 -248,000,000 -37,000,000 -12,000,000 -33,000,000 -248,000,000 -82,000,000 901,000,000 90,000,000 1,000,000 -19,000,000 -127,000,000 141,000,000 -132,000,000 69,000,000 -93,000,000    
      proceeds from issuance of common stock
    		                                          0        0 0       
      amortization of fixed maturity discounts and premiums
    		                                     -18,000,000 -44,000,000 -16,000,000 -19,000,000 24,000,000 -19,000,000 -3,000,000 24,000,000 82,000,000 34,000,000   -8,000,000 3,000,000 -28,000,000 -7,000,000 3,000,000 0 6,000,000 6,000,000 6,000,000 
      dividends paid to stockholders
    		                                              -45,000,000 -42,000,000 -44,000,000 -44,000,000 -44,000,000 -40,000,000 -39,000,000 -40,000,000 -42,000,000 -34,000,000 -34,000,000 -35,000,000 
      stock-based compensation awards exercised
    		                                              0 0 3,000,000 2,000,000 10,000,000 -1,000,000 16,000,000 14,000,000 17,000,000 12,000,000   
      acquisition of treasury stock
    		                                              0 0 0 -76,000,000 -24,000,000 -102,000,000 -765,000,000 -233,000,000 -325,000,000 -122,000,000 -74,000,000 -479,000,000 
      cash and cash equivalents at beginning of year
    		                                                          
      cash and cash equivalents at end of year
    		                                                          
      repayment and repurchase of long-term borrowings
    		                                           -70,000,000 -660,000,000 -79,000,000             
      proceeds from the issuance of long-term borrowings
    		                                       0                   
      less gain on sale from discontinued operations, net of taxes
    		                                                  2,000,000        
      cash received from sale of discontinued operations, net of cash sold
    		                                                  0 0       
      proceeds from issuance of non-recourse funding obligations
    		                                                  0 0   315,000,000 300,000,000 0 750,000,000 
      net increase in trading, held-for-sale investments and derivative instruments
    		                                                          
      net increase in trading and derivative instruments
    		                                             -56,000,000             
      proceeds from issuance of investment contracts
    		                                             773,000,000 1,297,000,000 2,297,000,000 2,463,000,000 1,547,000,000 2,158,000,000 1,637,000,000 2,330,000,000 1,877,000,000 2,161,000,000 1,811,000,000 1,718,000,000 2,056,000,000 
      redemption and benefit payments on investment contracts
    		                                             -2,803,000,000 -3,653,000,000 -3,328,000,000 -2,334,000,000 -2,207,000,000 -3,007,000,000 -2,559,000,000 -2,290,000,000 -2,262,000,000 -2,115,000,000 -2,569,000,000 -2,230,000,000 -2,597,000,000 
      cumulative effect of accounting changes, net of taxes
    		                                                          
      proceeds from issuance of long-term borrowings
    		                                                          
      capital contribution received from our former parent
    		                                                          
      less cash and cash equivalents of discontinued operations at end of year
    		                                                          
      cash and cash equivalents of continuing operations at end of year
    		                                                          
      less gain on sale of discontinued operations, net of taxes
    		                                                          
      purchases of trading securities and held-for-sale investments, net of proceeds from sales
    		                                               -2,000,000 0 12,000,000 -68,000,000        
      repayment of long-term debt
    		                                                   0       
      repayment of long-term borrowings
    		                                                          
      cumulative effect of accounting change
    		                                                          
      fixed maturities
    		                                                   1,560,000,000 1,625,000,000 1,320,000,000 2,037,000,000 1,372,000,000 1,464,000,000 1,338,000,000 
      fixed maturities and equity securities
    		                                                   1,724,000,000 1,565,000,000 1,749,000,000 3,603,000,000 765,000,000 1,582,000,000 1,336,000,000 
      less gain from discontinued operations, net of taxes
    		                                                          
      purchases of trading securities, net of proceeds from sales
    		                                                    -17,000,000 -3,000,000     
      capital contribution received from ge
    		                                                      0 1,000,000   
      less net income from discontinued operations
    		                                                     -10,000,000     
      adjustments to reconcile net income to net cash provided from operating activities:
    		                                                          
      corporate overhead allocation
    		                                                          
      net (gain) income from sale of discontinued operations
    		                                                          
      proceeds from sale of discontinued operations, net of cash disposal
    		                                                          
      proceeds from long-term borrowings
    		                                                          
      repayment of contingent note
    		                                                          
      cash transferred in connection with our corporate formation
    		                                                          
      cumulative effect of accounting policy change
    		                                                       0 0 -4,000,000 
      net earnings
    		                                                        317,000,000 334,000,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                                          
      mortgage loans
    		                                                        305,000,000 249,000,000 
      short-term borrowing activity
    		                                                          
      net realized investment losses
    		                                                         22,000,000 
      net commercial paper borrowings
    		                                                         229,000,000 
      net realized investment (gains) losses
    		                                                          
      net (earnings) from discontinued operations
    		                                                          
      operating cash flows from discontinued operations
    		                                                          
      mortgage and policy loans
    		                                                          
      proceeds from sales and securitizations of investments:
    		                                                          
      investing cash flows from discontinued operations
    		                                                          
      short-term investment activity
    		                                                          
      financing cash flows from discontinued operations
    		                                                          
      short-term borrowings activity
    		                                                          
      cash transferred in connection with our corporate reorganization
    		                                                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.